|
1AKJ
COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 AND THE T CELL CORECEPTOR CD8
Deposited 1997-05-21
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain D
22–141(120 aa)
Fragment:EXTRACELLULAR IGSF DOMAIN, RESIDUES 1 - 120, ALPHA CHAIN
Chain E
22–141(120 aa)
Fragment:EXTRACELLULAR IGSF DOMAIN, RESIDUES 1 - 120, ALPHA CHAIN
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.5;PROTEIN WAS CRYSTALLIZED FROM 12% PEG 20000, 100 MM MES, PH 6.5
|
Resolution 2.65 Å
R-free 0.276
|
|
1CD8
CRYSTAL STRUCTURE OF A SOLUBLE FORM OF THE HUMAN T CELL CO-RECEPTOR CD8 AT 2.6 ANGSTROMS RESOLUTION
Deposited 1992-01-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
22–135(114 aa)
|
Not recorded
|
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.60 Å
|
|
1Q69
Solution structure of T-cell surface glycoprotein CD8 alpha chain and Proto-oncogene tyrosine-protein kinase LCK fragments
Deposited 2003-08-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
209–227(19 aa)
Fragment:Human CD8 alpha
|
Not recorded
|
ZN ZINC ION × 1
|
SOLUTION NMR
NMR measurement conditions
pH 5.1;298 K;Pressure ambient
NMR sample composition
0.5 mM CD8a-Lck-Zn2+, U-15N,13C; 20 mM acetate, 20 mM NaCl, 0.15% beta-mercaptoethanol | 95% H2O/5% D2O
NMR sample composition
0.5 mM CD8a-Lck-Zn2+, U-15N; 20 mM acetate, 20 mM NaCl, 0.15% beta-mercaptoethanol | 95% H2O/5% D2O
NMR sample composition
0.5 mM CD8a-Lck-Zn2+; 20 mM acetate, 20 mM NaCl, 0.15% beta-mercaptoethanol | 100% D2O
NMR sample composition
1.0 mM CD8a-Lck-Cd2+; 20 mM acetate, 20 mM NaCl, 0.15% beta-mercaptoethanol | 100% D2O
|
Resolution not provided
|
|
2HP4
Computational design and crystal structure of an enhanced affinity mutant human CD8-alpha-alpha co-receptor
Deposited 2006-07-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
22–135(114 aa)
Fragment:HLA Co-receptor, Ig-like V-type
Chain B
22–135(114 aa)
Fragment:HLA Co-receptor, Ig-like V-type
|
Mutation:C33A/S53N
Mutation:C33A/S53N
|
SO4 SULFATE ION × 5
GOL GLYCEROL × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.5;291 K;25.5% PEG 8000, 0.085M Sodium Cacodylate, 0.17M Ammonium Sulphate, 15% Glycerol, 3% Ethylene Glycol, pH 6.50, VAPOR DIFFUSION, temperature 291K
|
Resolution 2.10 Å
R-free 0.233
|
|
2HP4
Computational design and crystal structure of an enhanced affinity mutant human CD8-alpha-alpha co-receptor
Deposited 2006-07-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain A
22–135(114 aa)
Fragment:HLA Co-receptor, Ig-like V-type
Chain B
22–135(114 aa)
Fragment:HLA Co-receptor, Ig-like V-type
|
Mutation:C33A/S53N
Mutation:C33A/S53N
|
SO4 SULFATE ION × 10
GOL GLYCEROL × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.5;291 K;25.5% PEG 8000, 0.085M Sodium Cacodylate, 0.17M Ammonium Sulphate, 15% Glycerol, 3% Ethylene Glycol, pH 6.50, VAPOR DIFFUSION, temperature 291K
|
Resolution 2.10 Å
R-free 0.233
|
|
3QZW
Plasticity of human CD8 binding to peptide-HLA-A*2402
Deposited 2011-03-07
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain G
22–135(114 aa)
Fragment:ectodomain (UNP residues 22-135)
Chain H
22–135(114 aa)
Fragment:ectodomain (UNP residues 22-135)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;288 K;0.1M MES monohydrate, pH 6.5, 12% w/v PEG 20000, VAPOR DIFFUSION, HANGING DROP, temperature 288K
|
Resolution 2.80 Å
R-free 0.260
|
|
3QZW
Plasticity of human CD8 binding to peptide-HLA-A*2402
Deposited 2011-03-07
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain I
22–135(114 aa)
Fragment:ectodomain (UNP residues 22-135)
Chain J
22–135(114 aa)
Fragment:ectodomain (UNP residues 22-135)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;288 K;0.1M MES monohydrate, pH 6.5, 12% w/v PEG 20000, VAPOR DIFFUSION, HANGING DROP, temperature 288K
|
Resolution 2.80 Å
R-free 0.260
|
|
7UMG
Crystal structure of human CD8aa-MR1-Ac-6-FP complex
Deposited 2022-04-06
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
22–141(120 aa)
Chain D
22–141(120 aa)
|
Not recorded
|
30W N-(6-formyl-4-oxo-3,4-dihydropteridin-2-yl)acetamide × 1
PO4 PHOSPHATE ION × 1
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;298 K;Na K Phosphate, PEG 1K and NaCl
|
Resolution 2.40 Å
R-free 0.218
|
|
8EW6
Anti-human CD8 VHH complex with CD8 alpha
Deposited 2022-10-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain W
22–141(120 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7;291 K;15% PEG 3350 and 0.1M succinic acid pH 7.0
|
Resolution 1.90 Å
R-free 0.245
|